Combined Approach Offers Hope to Lung Cancer Patients Who Become Resistant to Drugs
Weizmann Institute of ScienceDrug resistance is an all-too-common occurrence in cancer treatment. Now, working with physicians at Chaim Sheba Medical Center, the Weizmann Institute of Science’s Prof. Yossi Yarden has identified a three-drug combo that fends off drug resistance in lung cancer. This is particularly promising, as two of the medications are already in use.